312 related articles for article (PubMed ID: 27616634)
1. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets.
Dalal MR; Grabner M; Bonine N; Stephenson JJ; DiGenio A; Bieszk N
Diabetes Res Clin Pract; 2016 Nov; 121():17-26. PubMed ID: 27616634
[TBL] [Abstract][Full Text] [Related]
2. Individualized HbA
Lautsch D; Boggs R; Wang T; Gonzalez C; Milligan G; Rajpathak S; Malkani S; McLeod E; Carroll J; Higgins V
Adv Ther; 2022 Feb; 39(2):1016-1032. PubMed ID: 34951678
[TBL] [Abstract][Full Text] [Related]
3. Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.
Chow W; Miyasato G; Kokkotos FK; Bailey RA; Buysman EK; Henk HJ
Clin Ther; 2016 Sep; 38(9):2071-82. PubMed ID: 27596020
[TBL] [Abstract][Full Text] [Related]
4. Assessing achievement and maintenance of glycemic control by patients initiating basal insulin.
Wu N; Aagren M; Boulanger L; Friedman M; Wilkey K
Curr Med Res Opin; 2012 Oct; 28(10):1647-56. PubMed ID: 22937724
[TBL] [Abstract][Full Text] [Related]
5. Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II).
Weng J; Zhao J; Zhou Z; Guo X; Zou D; Ji Q; Tong N; Li Q; Zhu J; Li Q; Qin G; Feng P; Yang L; Gao Z; Chen L; Li H; Li Y; Zeng L; Zhu D; Lu J; Luo T; Cui N
J Diabetes; 2020 Jan; 12(1):66-76. PubMed ID: 31222955
[TBL] [Abstract][Full Text] [Related]
6. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus.
Chien MN; Chen YL; Hung YJ; Wang SY; Lu WT; Chen CH; Lin CL; Huang TP; Tsai MH; Tseng WK; Wu TJ; Ho C; Lin WY; Chen B; Chuang LM
J Diabetes Investig; 2016 Nov; 7(6):881-888. PubMed ID: 27181199
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.
Meloni AR; DeYoung MB; Han J; Best JH; Grimm M
Cardiovasc Diabetol; 2013 Mar; 12():48. PubMed ID: 23522121
[TBL] [Abstract][Full Text] [Related]
9. The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Meneghini LF; Mauricio D; Orsi E; Lalic NM; Cali AMG; Westerbacka J; Stella P; Candelas Dea C; Pilorget V; Perfetti R; Khunti K;
Diabetes Obes Metab; 2019 Jun; 21(6):1429-1436. PubMed ID: 30768845
[TBL] [Abstract][Full Text] [Related]
10. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.
Levin P; Zhou S; Durden E; Farr AM; Gill J; Wei W
Clin Ther; 2016 Jan; 38(1):110-21. PubMed ID: 26681210
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
Mata-Cases M; Mauricio D; Franch-Nadal J
J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin.
Buysman EK; Anderson A; Bacchus S; Ingham M
Adv Ther; 2017 Apr; 34(4):937-953. PubMed ID: 28251556
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
15. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
[TBL] [Abstract][Full Text] [Related]
16. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.
Wysham CH; Lefebvre P; Pilon D; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Duh MS; Ingham M
J Diabetes Complications; 2019 Feb; 33(2):140-147. PubMed ID: 30554838
[TBL] [Abstract][Full Text] [Related]
18. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
19. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
[TBL] [Abstract][Full Text] [Related]
20. Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1 and type 2 diabetes in Finland in 2012-2019: Nationwide real-world evidence study.
Niskanen L; Hannula M; Kysenius K; Kaijala S; Lassenius MI; Valle TT
J Diabetes; 2024 May; 16(5):e13491. PubMed ID: 38273701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
